πŸ•΅οΈ Galectin Therapeutics Inc ($GALT)

SEC insider & ownership activity, last 12 months Β· CIK 1133416 Β· every row links its SEC filing

Over the last 12 months insiders sold $6.4M against $26K of open-market buying. 10X Fund, L.P. sold $1.7M (Apr–Dec). 2 planned sales are pending, the largest $39K (Harold Shlevin). No red-flag 8-Ks in the window.

🚨 2 signals active β€” planned-vs-executed verdicts, pre-event flags, and cluster context live in the API and the alerts bot.
Aug 2025: net +$0 Sep 2025: net -$145K Oct 2025: net -$247K Nov 2025: net -$1.8M Dec 2025: net -$2.7M Jan 2026: net -$787K Mar 2026: net +$0 Mar 2026: net +$0 Apr 2026: net +$0 May 2026: net -$2K Jun 2026: net -$437K Jul 2026: net -$83K
Monthly net open-market insider flow, last 12 months (up = net buying)

Insider flow

2 buyers, $26K (4 lots) Β· 5 sellers, $6.4M (71 lots)

InsiderBuysBoughtSellsSoldLast
10X Fund, L.P.0– 8$1.7MDec 16, 2025
Harold H. Shlevin0– 14$1.6MJun 29, 2026
Jamil Khurram0– 17$1.4MJul 14, 2026
Jack W. Callicutt0– 21$1.0MJan 6, 2026
Lewis Joel0– 11$710KJan 6, 2026
Kevin D. Freeman1$20K 0–Dec 23, 2025
Eldred Kary3$6K 0–Feb 6, 2026

5%+ holders

No current 5%+ beneficial-ownership positions on file.

Planned insider sales (Form 144)

SellerPlannedApprox. sale date
Harold Shlevin$112KJun 29, 2026 filing β†—
Jamil Khurram$341KJun 26, 2026 filing β†—
Harold Shlevin$39KJun 26, 2026 filing β†—
Jamil Khurram$26KJun 23, 2026 filing β†—
Jack W. Callicutt$252KJan 2, 2026 filing β†—
Lewis Joel$353KJan 2, 2026 filing β†—
Jamil Khurram$252KJan 2, 2026 filing β†—
Harold H. Shlevin$1.8MJan 2, 2026 filing β†—
Jamil Khurram$33KDec 31, 2025 filing β†—
Jamil Khurram$151KDec 17, 2025 filing β†—
Lewis Joel$282KDec 17, 2025 filing β†—
Harold Shlevin$172KDec 17, 2025 filing β†—
Harold Shlevin$53KDec 15, 2025 filing β†—
Harold Shlevin$123KDec 12, 2025 filing β†—
Harold Shlevin$104KDec 9, 2025 filing β†—
Harold Shlevin$957KDec 8, 2025 filing β†—
Jamil Khurram$660KNov 13, 2025 filing β†—
Lewis Joel$345KSep 12, 2025 filing β†—
Jack W. Callicutt$909KSep 12, 2025 filing β†—

Material events (8-K)

ItemEvent date
Reg FD disclosure (7.01)Jun 23, 2026 filing β†—
Financial Statements and Exhibits (9.01)Jun 23, 2026 filing β†—
Earnings (2.02)May 15, 2026 filing β†—
Financial Statements and Exhibits (9.01)May 15, 2026 filing β†—
Earnings (2.02)Mar 31, 2026 filing β†—
Financial Statements and Exhibits (9.01)Mar 31, 2026 filing β†—
Officer/director changes (5.02)Mar 12, 2026 filing β†—
Financial Statements and Exhibits (9.01)Mar 12, 2026 filing β†—
Officer/director changes (5.02)Jan 16, 2026 filing β†—
Officer/director changes (5.02)Jan 10, 2026 filing β†—
Material agreement (1.01)Dec 19, 2025 filing β†—
Financial Statements and Exhibits (9.01)Dec 19, 2025 filing β†—
Shareholder vote (5.07)Dec 3, 2025 filing β†—
Reg FD disclosure (7.01)Dec 3, 2025 filing β†—
Financial Statements and Exhibits (9.01)Dec 3, 2025 filing β†—
Earnings (2.02)Nov 14, 2025 filing β†—
Financial Statements and Exhibits (9.01)Nov 14, 2025 filing β†—
Reg FD disclosure (7.01)Nov 10, 2025 filing β†—
Financial Statements and Exhibits (9.01)Nov 10, 2025 filing β†—
Reg FD disclosure (7.01)Sep 8, 2025 filing β†—
Financial Statements and Exhibits (9.01)Sep 8, 2025 filing β†—
Earnings (2.02)Aug 14, 2025 filing β†—
Financial Statements and Exhibits (9.01)Aug 14, 2025 filing β†—